logo
Just how many Americans are taking GLP-1s now

Just how many Americans are taking GLP-1s now

Axios27-05-2025

More than 2% of Americans are taking the blockbuster class of GLP-1 drugs for overweight or obesity, up nearly 600% over six years, according to a report from FAIR Health given to Axios first.
Why it matters: The data from FAIR Health's repository of over 51 billion commercial healthcare claim records shows the explosion in use of the drugs specifically for weight loss — roughly half of all users.
Details: In all, roughly 4% of Americans were taking GLP-1 drugs in 2024 for either overweight, obesity or Type 2 diabetes (their original approved use).
The data shows Novo Nordisk's Ozempic is still by far the most commonly taken GLP-1, followed by Eli Lilly's Mounjaro.
The percentage of adults who were prescribed a GLP-1 drug but did not have bariatric surgery increased from 2.5% in 2019 to 11.2% in 2024 while the the percentage of adult patients who had bariatric surgery decreased 41.8%.
Yes, but: The data still shows a dearth of treatment for patients with overweight or obesity.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Drugs alone not the answer', says top GP as he talks about weight loss jabs
‘Drugs alone not the answer', says top GP as he talks about weight loss jabs

Yahoo

time2 hours ago

  • Yahoo

‘Drugs alone not the answer', says top GP as he talks about weight loss jabs

A leading GP and TV medic has told fitness industry professionals gathered in Bolton that drugs alone are not the way to fight obesity. Dr Hussain Al-Zubaidi, a regular guest on Channel 4's "Steph's Packed Lunch" and the lifestyle and physical activity lead for the Royal College of General Practitioners, shared this sentiment at a professional development event for the health, fitness, and wellbeing sector. He was addressing the professionals, at the Bolton Arena Community Sports Village, on the roll-out of GLP-1 drugs, sometimes referred to colloquially as fat jabs or fat pills. These medicines, which can be taken as tablets or injections, are used to treat type 2 diabetes and can aid weight loss by reducing a patient's appetite. Dr Al-Zubaidi said: "The roll-out of GLP-1s within primary care is very much the hot topic at the moment. "It is going to transform how we deliver primary care – and a lot of other things. "As we roll out GLP-1 therapies in primary care, we must resist the temptation to settle for the minimal scalable model of lifestyle support. "I was emphasising that people deserve better than that. "Our patients deserve a comprehensive, multi-component approach – nutrition, behavioural and psychological support, sleep and stress management, physical activity, and addiction care all working in harmony." His remarks come during an ongoing debate within the fitness sector about the role of GLP-1s in addressing obesity. The event was hosted by the LFX network in partnership with GM Active, a group made up of 12 leisure and community organisations – including Bolton Arena – that manage most publicly owned leisure and physical activity facilities on behalf of the 10 authorities across Greater Manchester. GM Active chair, Andy King, said: "It's not often a 'moment in time' occurs that you know will be considered a 'turning point' in the future, yet this event will be one of those, I am sure. "Thanks to the LFX network, GM Active is set fair to really understand how we can support those people who, through one way or another, have opted to utilise these tools to assist them to lose weight and help them to sustain their gains for the longer term through pragmatic and people-centred, wrap-around support." READ MORE: Bolton charity boss honoured with invite to Palace garden party Three Bolton businesses named for not paying minimum wage 'Top local chippy' nominated for award - cast your vote Dr Al-Zubaidi added: "The fitness professionals in that packed room have shown they're ready to play their part – now it's time for all of us to turn that eagerness into action." Neil Hutchinson, managing director of Bolton Arena Community Sports Village, said: "We've been working on a new health and wellbeing strategy for Bolton over the last six months, so I was keen to host this event and be at the front of this discussion. "We aim to be on the front foot with this in Bolton and ready to support local GPs and primary care in this revolutionary healthcare development."

Rockefeller Foundation Releases New Polling Data: Majority of Americans Want Food is Medicine Programs
Rockefeller Foundation Releases New Polling Data: Majority of Americans Want Food is Medicine Programs

Yahoo

time2 hours ago

  • Yahoo

Rockefeller Foundation Releases New Polling Data: Majority of Americans Want Food is Medicine Programs

Nearly 80% of Americans think food and nutrition should be covered by insurance to address chronic disease NEW YORK, June 12, 2025 /PRNewswire/ -- New polling data from The Rockefeller Foundation shows that more than four in five adults in the United States – across demographics, income levels, party affiliations, and geographies – support integrating Food is Medicine (FIM) programs into U.S. healthcare. The survey, conducted by Hattaway Communications, highlights high interest but low public awareness of FIM programs, which aim to treat and manage chronic disease by increasing access to nutritious foods. The research underscores the perceived benefits of Food is Medicine programs, with 79% of respondents reporting that FIM programs would personally help them eat better after they received a definition of the intervention. "Americans want nutrition and food solutions to help them eat better, improve their health, and save money," said Dr. Rajiv J. Shah, President of The Rockefeller Foundation. "We know that these programs are effective in helping patients manage diet-related chronic disease and are cost-effective too. Now, it's even clearer that there is a huge opportunity to improve Americans' health outcomes by investing in low-cost, individualized Food is Medicine solutions that are both proven and popular." Chronic diseases, such as diabetes, obesity, and heart disease, impact an estimated 133 million Americans—more than 38% (or one-third) of the total U.S. population—and cost the United States $1.1 trillion per year (equivalent to what the U.S. spends on food itself). The vast majority of chronic conditions are diet-related: In the United States alone, poor diets contribute to 500,000 deaths annually. Modeling on medically tailored meals shows that investing in FIM programs could save an estimated $32.1 billion a year, significantly reducing Americans' healthcare costs. Even still, only 13% of Americans polled said they knew about FIM programs, which include interventions such as medically tailored meals and prescriptions for accessing fruits and vegetables, coupled with nutrition support. When presented with the definition of what they entail, survey respondents (84%) resoundingly supported the efforts. Some of the key findings include: More than 4 in 5 Americans believe U.S. healthcare should offer more food and nutrition programs to treat and manage illnesses. Nearly 9 in 10 patients would prefer to rely more on healthy eating than on medications to manage their conditions. Nearly 4 in 5 Americans think that Food is Medicine programs should be covered by both public and private insurance, including 85% of self-identified Democrats and 78% of Republicans. 84% of respondents believed FIM could help improve the overall quality of health in the United States. 79% of respondents said FIM programs could help them personally. 49% of the American public and 67% of healthcare workers view high costs of nutritious food as the single largest barrier to eating well. "We are seeing a growing awareness of diet-related diseases and their consequences in the U.S.," said Devon Klatell, Vice President for the Food Initiative at The Rockefeller Foundation. "This polling data shows that Americans want more support to eat well and live well. Food is Medicine programs are one tool that health care practitioners and providers must be considering as they work to address chronic disease in America." The Rockefeller Foundation commissioned Hattaway Communications to conduct the survey, which polled respondents across all 50 states between February 28 and March 11, 2025. The survey sampled 2,271 respondents, including 1,135 patients and 399 healthcare workers. The sample was weighted by gender and education to align with the actual proportions within the population and is representative of racial demographics across the U.S. Since 2019, The Rockefeller Foundation has supported Food is Medicine programs and invested in research to improve their effectiveness and understand the benefits and costs. As part of this effort, The Foundation announced its $100 million investment to expand access to Food is Medicine, including supporting vital research like the American Heart Association's Health Care by Food Initiative. The Foundation also initiated partnerships with the U.S. Department of Veterans Affairs and the U.S. Department of Health and Human Services to speed the integration of Food Is Medicine into health systems. In February 2025, The Rockefeller Foundation announced $3.5 million in grant funding to support small and mid-scale U.S. farmers, improve health outcomes for people with chronic disease, mitigate rising health care costs in California, Hawaii, Maryland, Massachusetts, Mississippi, North Carolina, Oregon, Rhode Island, Virginia, and Washington, D.C., and advance state-based efforts to include FIM interventions as a medically covered benefit under Medicaid programs. About The Rockefeller FoundationThe Rockefeller Foundation is a pioneering philanthropy built on collaborative partnerships at the frontiers of science, technology, and innovation that enable individuals, families, and communities to flourish. We make big bets to promote the wellbeing of humanity. Today, we are focused on advancing human opportunity and reversing the climate crisis by transforming systems in food, health, energy, and finance. For more information, sign up for our newsletter at and follow us on X @RockefellerFdn and LinkedIn @the-rockefeller-foundation. Media Contact:Ashley Chang, The Rockefeller Foundation: media@ View original content: SOURCE The Rockefeller Foundation Sign in to access your portfolio

Eating this Middle Eastern staple daily can lower your cholesterol: study
Eating this Middle Eastern staple daily can lower your cholesterol: study

Yahoo

time2 hours ago

  • Yahoo

Eating this Middle Eastern staple daily can lower your cholesterol: study

Give peas a chance! A little legume widely beloved in the Middle Eastern world can offer massive benefits to your heart, a new study has found. And the best part is that this versatile, beige gem is incredibly affordable and probably already in your pantry. The research — recently presented at the NUTRITION 2025 conference — identified chickpeas as the key to significantly lowering cholesterol and inflammation in people with pre-diabetes. More research would be needed to gain a larger sense of the health benefits, particularly in people who are not prediabetic. The study included only 72 participants and lasted just 12 weeks, and the results were similar to eating white rice. However, the findings align with other research indicating chickpeas lead the way in heart-healthy foods. The hummus veg's high fiber content, particularly soluble fiber, is believed to bind with cholesterol in the digestive system and help flush it out of the body. The fiber also promotes healthy gut bacteria and keeps the bowel moving, while chickpeas' low glycemic index can contribute to better blood sugar levels. Legumes in general can mimic the hunger-killing effects of drugs like Ozempic and Wegovy, thereby promoting weight loss by keeping you fuller for longer. A cup of chickpeas can deliver over 12.5 grams of fiber and nearly 15 grams of plant-based protein — all for under 270 calories. They're also a rich source of iron, potassium and magnesium — essential nutrients that support overall health. The new study found that black beans had a similar effect on heart health, which is no real surprise. A cup of cooked black beans provides about 15 grams of protein and 15 grams of fiber at under 230 calories. They're also rich in antioxidants — particularly anthocyanins, the same compounds that give blueberries their health rap — which help fight inflammation and may reduce the risk of chronic conditions like heart disease and cancer. Plus, black beans boast key nutrients like folate, iron, magnesium and potassium, which support everything from brain function to healthy blood pressure. 'The soluble fiber in these legumes helps to lower cholesterol by reducing how much is absorbed into the bloodstream,' registered dietitian Maddie Gallivan, who was not involved with the new study, told Medical News Today. 'When eaten as part of a diverse, plant-rich diet, beans and chickpeas can support a healthy gut microbiome.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store